4//SEC Filing
Mahatme Ujwala 4
Accession 0000921895-21-000542
CIK 0001599298other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:55 PM ET
Size
5.6 KB
Accession
0000921895-21-000542
Insider Transaction Report
Form 4
Mahatme Ujwala
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-19+25,000→ 238,340 totalExercise: $7.33From: 2021-12-31Exp: 2031-02-19→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001823894
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:55 PM ET
- Size
- 5.6 KB